Janus Henderson Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,081
| Closed | -$34.7K | – | 2605 |
|
|
2023
Q1 | $34.7K | Sell |
11,081
-727,548
| -98% | -$2.28M | ﹤0.01% | 2673 |
|
|
2022
Q4 | $4.36M | Sell |
738,629
-898,865
| -55% | -$5.3M | ﹤0.01% | 893 |
|
|
2022
Q3 | $14.4M | Buy |
1,637,494
+787,894
| +93% | +$6.91M | 0.01% | 753 |
|
|
2022
Q2 | $6.41M | Sell |
849,600
-237,182
| -22% | -$1.79M | ﹤0.01% | 793 |
|
|
2022
Q1 | $26.4M | Buy |
1,086,782
+40,837
| +4% | +$991K | 0.01% | 683 |
|
|
2021
Q4 | $33.7M | Sell |
1,045,945
-2,943
| -0.3% | -$94.8K | 0.01% | 661 |
|
|
2021
Q3 | $46.9M | Sell |
1,048,888
-84,241
| -7% | -$3.76M | 0.02% | 571 |
|
|
2021
Q2 | $42.9M | Sell |
1,133,129
-162,461
| -13% | -$6.15M | 0.02% | 611 |
|
|
2021
Q1 | $46.5M | Sell |
1,295,590
-2,019
| -0.2% | -$72.4K | 0.02% | 572 |
|
|
2020
Q4 | $40.4M | Buy |
+1,297,609
| New | +$40.4M | 0.02% | 593 |
|